Shop
Description
Carvedi-Denk 25mg Tablets contain carvedilol, a medication that combines beta-blocker and alpha-blocker properties. It is primarily used to treat conditions such as hypertension (high blood pressure), chronic stable angina pectoris, and chronic heart failure. ([fdaghana.gov.gh](https://fdaghana.gov.gh/wp-content/uploads/2025/08/Carvedi-Denk-25mg-Tablet-Carvedilol-SmPC.pdf?utm_source=openai))
Carvedilol works by blocking beta-adrenergic receptors, which reduces heart rate and blood pressure, and by blocking alpha-adrenergic receptors, which helps dilate blood vessels. This combined action reduces the workload on the heart and improves blood flow. ([fdaghana.gov.gh](https://fdaghana.gov.gh/wp-content/uploads/2025/08/Carvedi-Denk-25mg-Tablet-Carvedilol-SmPC.pdf?utm_source=openai))
The tablets are taken orally, typically once or twice daily, with or after meals. Dosage is adjusted based on the condition being treated and patient response. ([fdaghana.gov.gh](https://fdaghana.gov.gh/wp-content/uploads/2025/08/Carvedi-Denk-25mg-Tablet-Carvedilol-SmPC.pdf?utm_source=openai))
Common side effects include dizziness, fatigue, low blood pressure, slow heart rate, and gastrointestinal issues. It should be used with caution in patients with asthma, certain heart conditions, or liver problems. ([fdaghana.gov.gh](https://fdaghana.gov.gh/wp-content/uploads/2025/08/Carvedi-Denk-25mg-Tablet-Carvedilol-SmPC.pdf?utm_source=openai))
Please note that a rapid alert notification was issued regarding Carvedi-Denk 25mg Tablets due to quality concerns. The National Medicines Regulatory Authority of Cote d’Ivoire reported that the stability analysis results of the product were out of specification, indicating potential quality issues. ([wp.africanpharmaceuticalreview.com](https://wp.africanpharmaceuticalreview.com/rapid-alert-notification-issued-on-brand-of-carvedilol/?utm_source=openai))
Given these concerns, it is advisable to consult with a healthcare professional before using this medication.
Reviews
There are no reviews yet.